Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Lineage Cell Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 130
- +12 vs. Q4 2025
- Shares held
- 111.7M
- +24.3M (+27.8%) vs. Q4 2025
- Total value
- $176.5M
- +$30.6M (+20.9%) vs. Q4 2025
- New holders
- 24
- 37 more added
- Sold out
- 12
- 26 more reduced
5 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $152.7M |
| Q1 2026 | 130 | $176.5M |
| Q4 2025 | 123 | $169.8M |
| Q3 2025 | 112 | $148.6M |
| Q2 2025 | 129 | $88.4M |
| Q1 2025 | 127 | $49.7M |
| Q4 2024 | 126 | $53.8M |
| Q3 2024 | 114 | $85.6M |
| Q2 2024 | 113 | $94.2M |
| Q1 2024 | 116 | $138.3M |
| Q4 2023 | 115 | $82.5M |
| Q3 2023 | 104 | $89.1M |
| Q2 2023 | 107 | $106.6M |
| Q1 2023 | 116 | $104.7M |
| Q4 2022 | 106 | $76.2M |
| Q3 2022 | 104 | $73.1M |
| Q2 2022 | 100 | $102.7M |
| Q1 2022 | 109 | $112.3M |
| Q4 2021 | 124 | $182.0M |
| Q3 2021 | 115 | $191.7M |
| Q2 2021 | 115 | $208.5M |
| Q1 2021 | 102 | $141.8M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 193,308 | $305.4K | 0.00% | +1,348+0.7% | Added |
| McMillan Office, Inc. | 216,000 | $341.3K | 0.04% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 221,000 | $349.2K | 0.01% | 00.0% | Unchanged |
| HRT Financial LP | 232,264 | $366.0K | 0.00% | +232,264 | New |
| Qube Research & Technologies Ltd | 259,561 | $410.1K | 0.00% | +48,213+22.8% | Added |
| Point72 Asset Management, L.P. | 304,363 | $480.9K | 0.00% | +144,955+90.9% | Added |
| EAM Investors, LLC | 346,615 | $547.7K | 0.06% | −95,606−21.6% | Reduced |
| Barclays PLC | 393,309 | $621.4K | 0.00% | +44,799+12.9% | Added |
| Bank of America Corp | 419,355 | $662.6K | 0.00% | +221,506+112.0% | Added |
| SEI Investments Co | 422,274 | $667.2K | 0.00% | +152,963+56.8% | Added |
| Northern Trust Corp | 499,127 | $788.6K | 0.00% | +19,854+4.1% | Added |
| Red Crane Wealth Management, LLC | 597,263 | $943.7K | 0.78% | 00.0% | Unchanged |
| Jane Street Group, LLC | 993,208 | $1.57M | 0.00% | −11,586−1.2% | Reduced |
| State Street Corp | 1,090,111 | $1.72M | 0.00% | +73,900+7.3% | Added |
| Goldman Sachs Group Inc | 1,169,427 | $1.85M | 0.00% | −269,319−18.7% | Reduced |
| Susquehanna International Group, LLP | 1,304,685 | $2.06M | 0.00% | +598,270+84.7% | Added |
| Vanguard Fiduciary Trust Co | 1,324,158 | $2.09M | 0.00% | +1,324,158 | New |
| UBS Group AG | 1,370,461 | $2.17M | 0.00% | +1,187,334+648.4% | Added |
| Morgan Stanley | 1,868,491 | $2.95M | 0.00% | −130,172−6.5% | Reduced |
| Renaissance Technologies LLC | 2,125,100 | $3.36M | 0.01% | −279,700−11.6% | Reduced |
| Geode Capital Management, LLC | 2,523,114 | $3.99M | 0.00% | +61,921+2.5% | Added |
| Marshall Wace, LLP | 3,065,033 | $4.84M | 0.01% | +1,702,972+125.0% | Added |
| Armistice Capital, LLC | 3,182,799 | $5.03M | 0.17% | +3,182,799 | New |
| BlackRock, Inc. | 3,864,757 | $6.11M | 0.00% | +30,644+0.8% | Added |
| Fifth Third Bancorp | 4,600,000 | $7.27M | 0.01% | +4,600,000 | New |
| Raffles Associates LP | 5,362,788 | $8.47M | 7.35% | 00.0% | Unchanged |
| Millennium Management LLC | 5,561,374 | $8.79M | 0.01% | +3,450,955+163.5% | Added |
| Defender Capital, LLC. | 6,729,599 | $10.6M | 3.77% | −99,500−1.5% | Reduced |
| Vanguard Capital Management LLC | 8,318,685 | $13.1M | 0.00% | +8,318,685 | New |
| Broadwood Capital Inc | 49,560,992 | $78.3M | 5.52% | 00.0% | Unchanged |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −84,600−100.0% | Sold out |
| Nwam LLC | 0 | $0 | 0.00% | −62,131−100.0% | Sold out |
| Fort Sheridan Advisors LLC | 0 | $0 | 0.00% | −55,177−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −30,632−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −23,447−100.0% | Sold out |
| DLD Asset Management, LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −14,789−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,800−100.0% | Sold out |
| Sprott Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −252−100.0% | Sold out |
| Strategic Investment Solutions, Inc. | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| ORG Partners LLC | – | – | – | – | Not filed |
| Trust Co of Vermont | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |